Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is up over 5% in pre-market trading after the company announced the appointment of new CEO Joseph Papa, …
Anavex Life Sciences Corp. (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer’s disease, other central …
Optimistic views on Alzheimer remedy in its making by Anavex Life Sciences Corp (NYSE:AVXL) and improved earnings report by Cytosorbents Corp (NASDAQ:CTSO) caused analysts …
Many investors hope to win big on biotech stocks as shares can sky rocket when there is good news. Analysts explain why there are plenty …
In a research report released Monday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Anavex Life Sciences Corp. (NASDAQ:AVXL), with a …
Chimerix Inc (NASDAQ:CMRX) is up 5% in pre-market trading following news that Point 72 Asset Management showed a 5.3% stake in the company …
Maxim’s healthcare analyst Jason Kolbert reiterated coverage on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and cell therapy company Cytori Therapeutics Inc (NASDAQ:CYTX).
Anavex Life Sciences Corp. (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain …
Analysts are weighing in on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and Israeli pharma company Oramed Pharmaceuticals, Inc.
Maxim’s healthcare analyst Jason Kolbert weighted in today on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and stem cell research company StemCells Inc (NASDAQ:STEM).
